Refine Search

  •  
  •  
NY jury convicts former SAC Capital Advisors portfolio manager of insider trading charges

...20-minute phone call with Martoma a day before the Stamford, Conn.-based firm began selling a large position in pharmaceutical stocks that enabled what prosecutors said were mammoth illegal profits.Martoma is the eighth portfolio manager or research...

http://chronicle.augusta.com/news/business/2014-02-06/ny-jury-convicts-former-sa
Merger market weakens

...world's largest pharmaceutical company in the largest corporate merger ever. But even as investors fled from pharmaceutical stocks, Wall Street analysts continued betting on which companies were likely to come together. "This definitely doesn't...

http://chronicle.augusta.com/stories/1998/02/25/bus_223104.shtml
Business
Stocks fall as Nasdaq, S&P set new 2004 lows

...The Nasdaq composite index and Standard & Poor's 500 both closed at new lows for the year. Health care and pharmaceutical stocks rose as Mylan Laboratories Inc. made a $4 billion all-stock offer for King Pharmaceuticals Inc. Financial...

http://chronicle.augusta.com/stories/2004/07/27/fin_423374.shtml
Finance
Pharmaceutical industry may benefit from Republican win

...which studies the drug industry. "I'm sure they are elated right now." Investors are also optimistic. Pharmaceutical stocks rose an average of 2.25 percent in the two days following the election compared with a 1.12 percent increase...

http://chronicle.augusta.com/stories/2002/11/11/bus_357842.shtml
Business
Focus on the things that matter

...unemployment. 7. Why we pushed a prescription-drug program that has phony numbers. (If you are already rich, buy pharmaceutical stocks). 8. Why President Bush never had to fully address his National Guard attendance, but John Kerry must address...

http://chronicle.augusta.com/stories/2004/05/21/let_416280.shtml
Letters
Stocks rise on profit-taking in spite of mixed economic data

...climbed 95 cents to $48.55 after meeting analysts' expectations with a 30 percent rise in quarterly earnings. Pharmaceutical stocks were mixed as federal authorities announced plans to take action against drug makers who mislead investors by...

http://chronicle.augusta.com/stories/2004/02/06/fin_403565.shtml
Finance
Wall Street lower on disappointing economic numbers

...quarters in a row, and that is what's driving this market. ... The overriding fact is optimism is growing." Pharmaceutical stocks saw gains Friday as congressional negotiations on a $400 billion Medicare drug plan appeared close to a conclusion...

http://chronicle.augusta.com/stories/2003/11/15/fin_391957.shtml
Finance
`98 market expected to slow down

...from demographics as baby boomers save and invest for retirement. Demographics are a boon for health care and pharmaceutical stocks, as well. "Seventy-six million baby boomers are entering the more expensive health care years," Mr. Skrainka...

http://chronicle.augusta.com/stories/1998/01/04/bus_220031.shtml
Business
Business briefs

Trading grows heavy in drug, tech stocks NEW YORK - A poor outlook for technology and pharmaceutical stocks prompted heavy selling in those sectors Tuesday, the only notable activity in an otherwise lackluster session. The Nasdaq composite...

http://chronicle.augusta.com/stories/2000/09/06/bus_294976.shtml
Business
Business briefs

...mixed; securities see rise NEW YORK - Profit-taking left stock prices narrowly mixed Tuesday, with bank and pharmaceutical stocks declining and securities firms gaining ground. The Dow Jones industrial average closed down 37.74 at 11,215...

http://chronicle.augusta.com/stories/2000/08/30/bus_297426.shtml
Business
1